Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
icosapent ethyl (vascepa) (1 trial)
bone marrow derived mesenchymal stem cells (2 trials)
Inflammation (Phase 4)
Lupus Nephritis (Phase 2)
Nephritis (Phase 2)
Pneumonia (Phase 2)
Weight Loss (Phase 4)
Trials (3 total)
Trial APIs (2 total)